Portal:RareDisease/News
From WikiPathways
(Difference between revisions)
| Line 31: | Line 31: | ||
* [[Pathway:WP5052|Nephrogenesis]] | * [[Pathway:WP5052|Nephrogenesis]] | ||
* [[Pathway:WP4830|GDNF/RET signalling axis]] | * [[Pathway:WP4830|GDNF/RET signalling axis]] | ||
| + | |||
| + | Disorders of sex development and fertility | ||
| + | * [[Pathway:WP4673|Genes involved in male infertility]] | ||
| + | * [[Pathway:WP4524|The alternative pathway of fetal androgen synthesis]] | ||
| + | * [[Pathway:WP4814|Somatic Sex determination]] | ||
| + | * [[Pathway:WP4842|Mammalian disorder of sexual development]] | ||
| + | * [[Pathway:WP4871|Kisspeptin/Kisspeptin Receptor System in the Ovary]] | ||
| + | * [[Pathway:WP4835|Peroxiredoxin 2 induced ovarian failure]] | ||
| + | |||
| + | Copy number variation syndromes (CNVs) - duplications or deletions | ||
| + | * [[Pathway:WP4905|1q21.1 copy number variation syndrome]] | ||
| + | * [[Pathway:WP4906|3q29 copy number variation syndrome]] | ||
| + | * [[Pathway:WP4657|22q11.2 copy number variation syndrome]] | ||
| + | * [[Pathway:WP3998|Prader-Willi and Angelman Syndrome]] | ||
| + | * [[Pathway:WP4932|7q11.23 copy number variation syndrome]] | ||
| + | * [[Pathway:WP4940|15q11.2 copy number variation syndrome]] | ||
| + | * [[Pathway:WP4942|15q13.3 copy number variation syndrome]] | ||
| + | * [[Pathway:WP4950|16p11.2 distal deletion syndrome]] | ||
| + | * [[Pathway:WP4949|16p11.2 proximal deletion syndrome]] | ||
Inborn errors of metabolism | Inborn errors of metabolism | ||
| Line 60: | Line 79: | ||
* [[Pathway:WP5028|Biochemistry of Glycine metabolism]] | * [[Pathway:WP5028|Biochemistry of Glycine metabolism]] | ||
* [[Pathway:WP5026|Biochemistry of Proline and Hydroxyproline]] | * [[Pathway:WP5026|Biochemistry of Proline and Hydroxyproline]] | ||
| - | + | * [[Pathway:WP4595|Urea cycle and associated pathways]] | |
| - | + | * [[Pathway:WP5029|Amino acid transport defects]] | |
| - | * [[Pathway: | + | * [[Pathway:WP4686|Leucine, isoleucine and valine metabolism]] |
| - | * [[Pathway: | + | * [[Pathway:WP5028|Glycine metabolism, including IEMs]] |
| - | * [[Pathway: | + | * [[Pathway:WP4157|GABA metabolism (aka GHB)]] |
| - | * [[Pathway: | + | * [[Pathway:WP5026|Proline and hydroxyproline pathways]] |
| - | * [[Pathway: | + | * [[Pathway:WP4688|Serine metabolism]] |
| - | + | * [[Pathway:WP5031|Biotin metabolism, including IEMs]] | |
| - | + | * [[Pathway:WP5037|Riboflavin and CoQ disorders]] | |
| - | + | * [[Pathway:WP4971|Phosphoinositides metabolism]] | |
| - | + | * [[Pathway:WP5030|Ethylmalonic encephalopathy]] | |
| - | * [[Pathway: | + | |
| - | + | ||
| - | + | ||
| - | * [[Pathway: | + | |
| - | * [[Pathway: | + | |
| - | * [[Pathway: | + | |
| - | * [[Pathway: | + | |
| - | * [[Pathway: | + | |
Revision as of 09:15, 28 May 2021
Explore rare disease pathways on WikiPathways:
- MECP2 and Associated Rett Syndrome
- Rett syndrome causing genes
- Amyotrophic lateral sclerosis (ALS)
- Fanconi Anemia Pathway
- Viral Acute Myocarditis
- Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
- Pathways Regulating Hippo Signaling
- po-Merlin Signaling Dysregulation
- Fragile X Syndrome
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway
- Prion disease pathway
- ERK Pathway in Huntington's Disease
- Parkinsons Disease Pathway
- Alzheimers Disease
- Joubert Syndrome
- Envelope proteins and their potential roles in EDMD physiopathology
- Ciliopathies
- NO metabolism in cystic fibrosis
Laminopathy pathways
- Lamin A-processing pathway
- The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
- The influence of laminopathies on Wnt signaling
- Interacting Laminopathic Pathways
CAKUT (congenital anomalies of the kidney and urinary tract)
- Development of uretric collection system
- Genes controlling nephrogenesis
- Nephrogenesis
- GDNF/RET signalling axis
Disorders of sex development and fertility
- Genes involved in male infertility
- The alternative pathway of fetal androgen synthesis
- Somatic Sex determination
- Mammalian disorder of sexual development
- Kisspeptin/Kisspeptin Receptor System in the Ovary
- Peroxiredoxin 2 induced ovarian failure
Copy number variation syndromes (CNVs) - duplications or deletions
- 1q21.1 copy number variation syndrome
- 3q29 copy number variation syndrome
- 22q11.2 copy number variation syndrome
- Prader-Willi and Angelman Syndrome
- 7q11.23 copy number variation syndrome
- 15q11.2 copy number variation syndrome
- 15q13.3 copy number variation syndrome
- 16p11.2 distal deletion syndrome
- 16p11.2 proximal deletion syndrome
Inborn errors of metabolism
- Neurotransmitter Disorders
- Purine Disorders
- Pyrimidine Disorder
- Purine metabolism
- Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
- Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
- Cerebral Organic Acidurias
- Glycosylation and related congenital defects
- Metabolic pathway of LDL, HDL and TG
- Classical pathway of steroidogenesis, including diseases
- Disorders of Phenylalanine and Tetrahydrobiopterin
- Tyrosine Metabolism
- Sulphur Amino Acids
- Disorders of Folate Metabolism and Transport
- MTHFR deficiency
- Vitamine B6-Dependent and Responsive Disorders
- Molybdenum (Moco) cofactor biosynthesis
- Cysteine and Methionine catabolism disorders
- Vitamin B12 Disorders
- Thiamine Disorders
- Disorders of the Krebs Cycle
- Oxysterols derived from cholesterol
- Biotin Metabolism
- Ethylmalonic Encephalopathy
- Amino acid transport defects
- Biochemistry of Glycine metabolism
- Biochemistry of Proline and Hydroxyproline
- Urea cycle and associated pathways
- Amino acid transport defects
- Leucine, isoleucine and valine metabolism
- Glycine metabolism, including IEMs
- GABA metabolism (aka GHB)
- Proline and hydroxyproline pathways
- Serine metabolism
- Biotin metabolism, including IEMs
- Riboflavin and CoQ disorders
- Phosphoinositides metabolism
- Ethylmalonic encephalopathy
